MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202641111016 A) filed by Dr B Nagaraj; Vijayalakshmi. T; Rathi Meena. S; Hirudhula. S; Gowsikan. D; Ibharim. Dm; and Mithra Shri. Sr on September 16, 2026, for Self-Regulating Pro Biotic Capsule That Activates Only At Inflammatory Ph.
Inventors include Vijayalakshmi. T; Rathi Meena. S; Hirudhula. S; Gowsikan. D; Ibharim. Dm; and Mithra Shri. Sr.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: This invention is about a pro biotic capsule that only works when it finds inflammation in the gastrointestinal tract. The pro biotic capsule is designed to deliver bacteria to the inflamed parts of the intestines and not to the healthy parts. The capsule has a core with bacteria and a special coating that protects it. This coating only breaks down when it finds inflammation, which has acid levels. When the capsule is in a healthy part of the digestive system it does not break down. When it finds an inflamed area, the special coating breaks down and the good bacteria are released. This pro biotic help to make the gut healthy reduce inflammation and heal the intestines. They also make the treatment work better. The pro biotic capsule is good because it helps the pro biotics survive longer and it only releases them where they are needed. This means the pro biotic can work on their own to help with diseases. The pro biotic capsule can be used to help with bowel disease Croon's disease, ulcerr active colitis and other problems with the gut. This invention is a way to deliver pro biotic that uses smart materials and targets the treatment to where it is needed. It is a way to help people with gut problems and it is good for the next generation of healthcare. The pro biotic capsule is a self-regulating capsule that activates only at inflammatory pH conditions within the gastrointestinal tract like the pro biotic capsule.
Disclaimer: Curated by HT Syndication.
